Pharmafile Logo
Pharmafocus logo
Advanced Search

Perry Evans to lead RSA Interims

pharmafile | March 11, 2011 | Appointment | Business Services, Sales and Marketing |  Perry Evens, RSA Interims, appointment, business services, rsa, sales and marketing 

UK-based life science search company RSA has appointed Perry Evans director of RSA Interims.

He joined the company in 2006 and has over 20 years of international recruitment experience, covering senior level executive search, contingency recruitment and interim management.

Perry said: “I am thrilled to be taking on this new position leading the talented and thriving interims team at RSA.

Advertisement

“I look forward to building upon the team’s success and continuing to develop our interims business through new and innovative approaches for clients and interim managers.”

Related Content

handshake2

Astellas selects Veeva Vault CRM as global commercial platform

Astellas has selected Veeva Vault CRM as its global customer relationship management (CRM) platform, with …

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025